Principal Scientist, ADME-PK
Company: Dyne Therapeutics
Location: Waltham
Posted on: January 1, 2026
|
|
|
Job Description:
Company Overview: Dyne Therapeutics is focused on delivering
functional improvement for people living with genetically driven
neuromuscular diseases. We are developing therapeutics that target
muscle and the central nervous system (CNS) to address the root
cause of disease. The company is advancing clinical programs for
myotonic dystrophy type 1 (DM1) and Duchenne muscular dystrophy
(DMD), and preclinical programs for facioscapulohumeral muscular
dystrophy (FSHD) and Pompe disease. At Dyne, we are on a mission to
deliver functional improvement for individuals, families and
communities. Learn more https://www.dyne-tx.com/ , and follow us on
X , LinkedIn and Facebook . Role Summary: The Principal Scientist,
ADME-PK in Preclinical Development (PCD) department utilizes their
knowledge in drug metabolism, ADME concepts, pharmacokinetics,
pharmacodynamic and bioanalytical principles to advance Dyne’s
efforts surrounding delivery of therapeutic payloads to muscle and
CNS tissues with the FORCE platform. This role is based in Waltham,
MA. Primary Responsibilities Include: Design and execute
internal/external preclinical studies to understand the
pharmacokinetics (PK) and absorption, metabolism, distribution, and
excretion (ADME) of Dyne’s drug candidates Represent PCD as the
ADME-PK subject matter expert on discovery and program teams
Partner with and support Research, Toxicology, Translational
Biomarkers, Clinical, Regulatory, Project Management and other Dyne
departments Collaborate with Clinical Pharmacology/Pharmacometrics
to develop quantitative tools to translate PK/PD relationship from
preclinical to clinical Author high quality Regulatory documents
including INDs, CTAs, and NDA/BLA filings. Prepare strategic and
science-based ADME strategies that meet regulatory requirements and
program goals Facilitate strategic scientific communication via
meetings, abstracts and manuscripts Education and Skill
Requirements: PhD in Pharmacokinetics, Pharmacology, Pharmaceutics,
Biomedical Sciences or other relevant field with >6 years (MS
with >8 years, BS with >12 years) of experience in the
biopharmaceutical industry, with evidence of drug development
experience Strong knowledge of drug metabolism, ADME concepts,
pharmacokinetics, pharmacodynamics and bioanalytical principles
Familiarity with regulatory submission including FIH dosing
strategy is highly desirable Proficient in using WinNonlin or other
pharmacokinetic software Excellent communication (verbal and
written) and presentation skills, as well as interpersonal skills
and the ability to represent PCD in a team environment Experience
with PK characterization of protein therapeutics or antibody-drug
conjugates (ADCs) is desired LI-Onsite MA Pay Range $159,000 -
$195,000 USD The pay range reflects the base pay range Dyne
reasonably expects to pay for this role at the time of posting.
Individual compensation depends on factors such as education,
experience, job-related knowledge, and demonstrated skills. The
statements contained herein reflect general details as necessary to
describe the principles functions for this job, the level of
knowledge and skill typically required, and the scope of
responsibility, but should not be considered an all-inclusive
listing of work requirements. Individuals may perform other duties
as assigned, including work in other functional areas to cover
absences or relief, to equalize peak work periods or otherwise
balance workload. Dyne Therapeutics is an equal opportunity
employer and will not discriminate against any employee or
applicant on the basis of age, color, disability, gender, national
origin, race, religion, sexual orientation, veteran status, or any
classification protected by federal, state, or local law.
Keywords: Dyne Therapeutics, Fall River , Principal Scientist, ADME-PK, Science, Research & Development , Waltham, Massachusetts